Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Glasdegib by Pfizer for Graft Versus Host Disease (GVHD): Likelihood of Approval
Glasdegib is under clinical development by Pfizer and currently in Phase II for Graft Versus Host Disease (GVHD). According to...
Data Insights
Glasdegib by Pfizer for Glioblastoma Multiforme (GBM): Likelihood of Approval
Glasdegib is under clinical development by Pfizer and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData, Phase...